BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Campbell NP, Villaflor VM. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 2010; 16(30): 3793-3803 [PMID: 20698042 DOI: 10.3748/wjg.v16.i30.3793]
URL: https://www.wjgnet.com/1007-9327/full/v16/i30/3793.htm
Number Citing Articles
1
Michele Fiore, Lucio Trodella, Sergio Valeri, Domenico Borzomati, Barnaba Floreno, Edy Ippolito, Pasquale Trecca, Luca Eolo Trodella, Rolando Maria D’Angelillo, Sara Ramella, Roberto Coppola. Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancerRadiation Oncology 2015; 10(1) doi: 10.1186/s13014-015-0564-8
2
Tristin Abair, Bing-e Xu, Aarati Ranganathan, Tim Quill, Edward Chu, David Cunningham. The Annual Meeting of the American Society of Clinical OncologyClinical Colorectal Cancer 2010; 9(4): 195 doi: 10.3816/CCC.2010.n.029
3
Xiao-Mei Zhang, Ming-Zhou Guo. The value of epigenetic markers in esophageal cancerFrontiers of Medicine in China 2010; 4(4): 378 doi: 10.1007/s11684-010-0230-3
4
Masanobu Nakajima, Hiroyuki Kato, Tatsuya Miyazaki, Takanori Inose, Naritaka Tanaka, Shigemasa Suzuki, Takehiko Yokobori, Makoto Sakai, Akihiko Sano, Keisuke Ieta, Makoto Sohda, Minoru Fukuchi, Hiroyuki Kuwano. An Absolute Standardized Uptake Value Is More Useful than the Decreased Rate of Uptake of FDG-PET to Predict Responses to Neoadjuvant Chemoradiotherapy for Esophageal CancerOpen Journal of Gastroenterology 2016; 6(11): 373 doi: 10.4236/ojgas.2016.611040
5
Lukas F. Liesenfeld, Peter Sauer, Markus K. Diener, Ulf Hinz, Thomas Schmidt, Beat P. Müller-Stich, Thilo Hackert, Markus W. Büchler, Anja Schaible. Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resectionBMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00995-2
6
John M. Findlay, Kevin M. Bradley, Lai Mun Wang, James M. Franklin, Eugene J. Teoh, Fergus V. Gleeson, Nicholas D. Maynard, Richard S. Gillies, Mark R. Middleton. Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized TherapyJournal of Nuclear Medicine 2017; 58(2): 266 doi: 10.2967/jnumed.116.176313
7
Carrie Luu, Marisa Amaral, Jason Klapman, Cynthia Harris, Khaldoun Almhanna, Sarah Hoffe, Jessica Frakes, Jose M Pimiento, Jacques P Fontaine. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?World Journal of Gastroenterology 2017; 23(46): 8193-8199 doi: 10.3748/wjg.v23.i46.8193
8
Keduovinuo K. Keditsu, Sabita Jiwnani, George Karimundackal, C. S. Pramesh. Multimodality Management of Esophageal CancerIndian Journal of Surgical Oncology 2013; 4(2): 96 doi: 10.1007/s13193-013-0216-0
9
Yun Yang, Ziyin Tian, Yanke Ding, Xiaojing Li, Ziheng Zhang, Liu Yang, Fangyu Zhao, Feng Ren, Rui Guo. EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 PathwayJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/1090287
10
Xiao-Fang Guo, Xiao-Fei Zhu, Wan-Cai Yang, Sheng-Hua Zhang, Yong-Su Zhen, Karl X. Chai. An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal CancerPLoS ONE 2014; 9(3): e92986 doi: 10.1371/journal.pone.0092986
11
Catarina Macedo-Silva, Vera Miranda-Gonçalves, Rui Henrique, Carmen Jerónimo, Isabel Bravo. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer RadioresistanceGenes 2019; 10(11): 927 doi: 10.3390/genes10110927
12
Prashant Sukharamwala, Daniel Hennessey, Thomas Wood, Shelly Singh, Carrie Ryan, Alexander Rosemurgy. Molecular profiles in foregut oncologyCancer Genetics 2016; 209(12): 537 doi: 10.1016/j.cancergen.2016.09.008
13
John M Findlay, Richard S Gillies, James M Franklin, Eugene J Teoh, Greg E Jones, Sara di Carlo, Fergus V Gleeson, Nicholas D Maynard, Kevin M Bradley, Mark R Middleton. Restaging oesophageal cancer after neoadjuvant therapy with 18F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgeryEuropean Radiology 2016; 26(10): 3519 doi: 10.1007/s00330-016-4227-4
14
Yu Liu, Deyao Xie, Chang Li, Chaoxi Lin, Jun Zhao. Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinomaOncology Letters 2017; 14(3): 2803 doi: 10.3892/ol.2017.6515
15
M. Mura Assifi, Xuyang Lu, Guido Eibl, Howard A. Reber, Gang Li, O. Joe Hines. Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trialsSurgery 2011; 150(3): 466 doi: 10.1016/j.surg.2011.07.006
16
R. J. L. F. Loffeld, P. E. P. Dekkers. Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily PracticeISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/205417
17
GANG LIN, XIAO-JIANG SUN, QIAN-BO HAN, ZHUN WANG, YA-PING XU, JIA-LEI GU, WEI WU, GU ZHANG, JIN-LIN HU, WEN-YONG SUN, WEI-MIN MAO. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinomaOncology Letters 2015; 10(2): 901 doi: 10.3892/ol.2015.3277
18
Lei Wang, Jianfang Feng, Xiaonan Chen, Wei Guo, Yuwen Du, Yuanyuan Wang, Wenqiao Zang, Shijie Zhang, Guoqiang Zhao. Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivoCancer Cell International 2014; 14(1) doi: 10.1186/s12935-014-0071-2
19
Tomas DaVee, Jaffer A Ajani, Jeffrey H Lee. Is endoscopic ultrasound examination necessary in the management of esophageal cancer?World Journal of Gastroenterology 2017; 23(5): 751-762 doi: 10.3748/wjg.v23.i5.751
20
Ari Kassardjian, Hanlin L. Wang. SMAD4-Expressing Pancreatic Ductal Adenocarcinomas Have Better Response to Neoadjuvant Therapy and Significantly Lower Lymph Node Metastasis RatesPancreas 2020; 49(9): 1153 doi: 10.1097/MPA.0000000000001636
21
Catarina Macedo-Silva, Vera Miranda-Gonçalves, Ana Lameirinhas, Joana Lencart, Alexandre Pereira, João Lobo, Rita Guimarães, Ana Teresa Martins, Rui Henrique, Isabel Bravo, Carmen Jerónimo. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinomaCell Death & Disease 2020; 11(12) doi: 10.1038/s41419-020-03279-y
22
Ming Wang, Liang Wang, Xiang He, Jinhua Zhang, Zhongcheng Zhu, Mingyun Zhang, Xingde Li. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathwayInternational Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4929
23
A. Herskovic, W. Russell, M. Liptay, M.J. Fidler, M. Al-Sarraf. Esophageal carcinoma advances in treatment results for locally advanced disease: reviewAnnals of Oncology 2012; 23(5): 1095 doi: 10.1093/annonc/mdr433
24
Juliana Yang, Ali A. Siddiqui, Thomas E. Kowalski, David E. Loren, Ammara Khalid, Ayesha Soomro, Syed M. Mazhar, Julian Rosé, Laura Isby, Michel Kahaleh, Ankush Kalra, Alex M. Sarkisian, Nikhil A. Kumta, Jose Nieto, Reem Z. Sharaiha. Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experienceSurgical Endoscopy 2017; 31(3): 1414 doi: 10.1007/s00464-016-5131-3
25
Lukas F. Liesenfeld, Thomas Schmidt, Christine Zhang-Hagenlocher, Peter Sauer, Markus K. Diener, Beat P. Müller-Stich, Thilo Hackert, Markus W. Büchler, Anja Schaible. Self-expanding Metal Stents for Anastomotic Leaks After Upper Gastrointestinal Cancer SurgeryJournal of Surgical Research 2021; 267: 516 doi: 10.1016/j.jss.2021.06.007
26
J.M. Findlay, M.R. Middleton, I. Tomlinson. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stageAnnals of Oncology 2015; 26(4): 624 doi: 10.1093/annonc/mdu449
27
Yan Jia, Yunsheng Yang, Malcolm V Brock, Baoping Cao, Qimin Zhan, Yazhuo Li, Yuanzi Yu, James G Herman, Mingzhou Guo. Methylation of TFPI-2 is an early event of esophageal carcinogenesisEpigenomics 2012; 4(2): 135 doi: 10.2217/epi.12.11
28
Ali A. Siddiqui, Avik Sarkar, Sara Beltz, Jason Lewis, David Loren, Thomas Kowalski, John Fang, Kristen Hilden, Douglas G. Adler. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapyGastrointestinal Endoscopy 2012; 76(1): 44 doi: 10.1016/j.gie.2012.02.036
29
Yun Yang, Ziyin Tian, Xinghua Zhao, Ya Li, Shuyan Duan. A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cellsOncology Letters 2020; 20(1): 877 doi: 10.3892/ol.2020.11638
30
Anthony J. Scholer, Abhineet Uppal, Shu‐Ching Chang, Debopriya Ghosh, Mary Garland‐ Kledzik, Juan Santamaria‐Barria, Adam Khader, Ahmed Dehal, Trevan Fischer, Melanie Goldfarb. Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinomaJournal of Surgical Oncology 2020;  doi: 10.1002/jso.26101
31
Alvin Gogineni, Maresa Caunt, Ailey Crow, Chingwei V. Lee, Germaine Fuh, Nicholas van Bruggen, Weilan Ye, Robby M. Weimer, Fabrizio Mattei. Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary MetastasisPLoS ONE 2013; 8(7): e68755 doi: 10.1371/journal.pone.0068755
32
Wenqing Cao, Jeffrey H Peters, Dylan Nieman, Meenal Sharma, Thomas Watson, JiangZhou Yu. Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitroBritish Journal of Cancer 2015; 113(5): 738 doi: 10.1038/bjc.2015.292
33
Takahiro Tsuchikawa, Masaki Miyamoto MD, Yoshiyuki Yamamura, Toshiaki Shichinohe, Satoshi Hirano, Satoshi Kondo. The Immunological Impact of Neoadjuvant Chemotherapy on the Tumor Microenvironment of Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology 2012; 19(5): 1713 doi: 10.1245/s10434-011-1906-x
34
Bassan J. Allan, Felipe Pedroso, Elisabeth R. Gennis, Alan S. Livingstone, Alberto Montero, Brian Lally, Bach Ardalan, Leonidas G. Koniaris, Naveenraj L. Solomon, Dido Franceschi. Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal AdenocarcinomasAnnals of Surgical Oncology 2013; 20(5): 1660 doi: 10.1245/s10434-012-2766-8
35
Ebru Cilbir, Suayib Yalcin. Textbook of Gastrointestinal Oncology2019; : 55 doi: 10.1007/978-3-030-18890-0_4
36
Kim Vaiphei, Saroj Kant Sinha, Rakesh Kochhar. Comparative Analysis of Oct4 in Different Histological Subtypes of Esophageal Squamous Cell Carcinomas in Different Clinical ConditionsAsian Pacific Journal of Cancer Prevention 2014; 15(8): 3519 doi: 10.7314/APJCP.2014.15.8.3519
37
J. Talvas, G. Garrait, N. Goncalves-Mendes, J. Rouanet, J. Vergnaud-Gauduchon, F. Kwiatkowski, P. Bachmann, C. Bouteloup, J. Bienvenu, M.-P. Vasson. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trialClinical Nutrition 2015; 34(5): 810 doi: 10.1016/j.clnu.2014.12.002
38
J M Findlay, K M Bradley, L M Wang, J M Franklin, E J Teoh, F V Gleeson, N D Maynard, R S Gillies, M R Middleton. Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerBritish Journal of Surgery 2017; 104(4): 408 doi: 10.1002/bjs.10435
39
Yu Fang, Dianchun Fang, Jianguo Hu. MicroRNA and its roles in esophageal cancerMedical Science Monitor 2012; 18(3): RA22 doi: 10.12659/MSM.882509
40
Maki Yamamoto, Jill M. Weber, Richard C. Karl, Kenneth L. Meredith. Minimally Invasive Surgery for Esophageal Cancer: Review of the Literature and Institutional ExperienceCancer Control 2013; 20(2): 130 doi: 10.1177/107327481302000206
41
Yajuan Lv, Meijuan Song, Xiufang Tian, Xinshuang Yv, Ning Liang, Jiandong Zhang. Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancerMedicine 2020; 99(36): e20993 doi: 10.1097/MD.0000000000020993
42
Thomas J. Hardacker, DuyKhanh Ceppa, Ikenna Okereke, Karen M. Rieger, Shadia I. Jalal, Julia K. LeBlanc, John M. DeWitt, Kenneth A. Kesler, Thomas J. Birdas. Treatment of Clinical T2N0M0 Esophageal CancerAnnals of Surgical Oncology 2014; 21(12): 3739 doi: 10.1245/s10434-014-3929-6
43
Feng Wang, Lan Zhang, Yue Xu, Yilin Xie, Shenglei Li. Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell CarcinomaFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.676156
44
Po-Kuei Hsu, Bing-Yen Wang, Chien-Sheng Huang, Yu-Chung Wu, Wen-Hu Hsu. Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after ResectionJournal of Gastrointestinal Surgery 2011; 15(4): 558 doi: 10.1007/s11605-011-1458-1
45
David Bunting, Richard Berrisford, Tim Wheatley, Lee Humphreys, Arun Ariyarathenam, Grant Sanders. Prospective cohort study of neoadjuvant therapy toxicity in the treatment of oesophageal adenocarcinomaInternational Journal of Surgery 2018; 52: 126 doi: 10.1016/j.ijsu.2018.02.023